Eindrückliche Verbesserung des Überlebens beim metastasierten HER2-low-Mammakarzinom – Etablierung einer neuen Subgruppe?

M. Pervan; H. Princk; L. Hanker; A. Rody; N. Bündgen; M. Banys-Paluchowski

doi:10.1007/s00761-022-01276-8

Eindrückliche Verbesserung des Überlebens beim metastasierten HER2-low-Mammakarzinom – Etablierung einer neuen Subgruppe?

Translated title of the contribution: Impressive improvements in survival for patients with HER2-low metastatic breast cancer—establishing a new subgroup?

M. Pervan^*, H. Princk, L. Hanker, A. Rody, N. Bündgen, M. Banys-Paluchowski

^*Corresponding author for this work

Translated title of the contribution	Impressive improvements in survival for patients with HER2-low metastatic breast cancer—establishing a new subgroup?
Original language	German
Journal	Onkologie
Volume	29
Issue number	2
Pages (from-to)	157-159
Number of pages	3
ISSN	2731-7226
DOIs	https://doi.org/10.1007/s00761-022-01276-8
Publication status	Published - 02.2023

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)
Centers: University Cancer Center Schleswig-Holstein (UCCSH)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00761-022-01276-8

Cite this

@article{8838493373c744de8c20b3b07fac573c,

title = "Eindr{\"u}ckliche Verbesserung des {\"U}berlebens beim metastasierten HER2-low-Mammakarzinom – Etablierung einer neuen Subgruppe?",

author = "M. Pervan and H. Princk and L. Hanker and A. Rody and N. B{\"u}ndgen and M. Banys-Paluchowski",

year = "2023",

month = feb,

doi = "10.1007/s00761-022-01276-8",

language = "Deutsch",

volume = "29",

pages = "157--159",

journal = "Onkologie",